Oncotarget

Research Papers:

c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma

Yari Ciribilli, Prashant Singh, Alberto Inga, Jürgen Borlak _

Metrics: PDF 527 views  |   HTML 399 views  |   ?  


Abstract

Yari Ciribilli1, Prashant Singh2, Alberto Inga1, Jürgen Borlak2

1Centre for Integrative Biology (CIBIO), University of Trento, 38123 Povo, Italy

2Centre for Pharmacology and Toxicology, Hannover Medical School, 30625 Hannover, Germany

Correspondence to:

Jürgen Borlak, email: Borlak.Juergen@mh-hannover.de

Keywords: c-Myc transgenic mouse model of papillary lung adenocarcinomas, whole genome transcriptome profiling, regulatory gene networks, c-Myc targeted regulators of cellular growth, c-Myc DNA binding activity

Received: March 01, 2016     Accepted: August 24, 2016     Published: September 01, 2016

ABSTRACT

c-Myc's role in pulmonary cancer metabolism is uncertain. We therefore investigated c-Myc activity in papillary lung adenocarcinomas (PLAC). Genomics revealed 90 significantly regulated genes (> 3-fold) coding for cell growth, DNA metabolism, RNA processing and ribosomal biogenesis and bioinformatics defined c-Myc binding sites (TFBS) at > 95% of up-regulated genes. EMSA assays at 33 novel TFBS evidenced DNA binding activity and ChIP-seq data retrieved from public repositories confirmed these to be c-Myc bound. Dual-luciferase gene reporter assays developed for RNA-Terminal-Phosphate-Cyclase-Like-1(RCL1), Ribosomal-Protein-SA(RPSA), Nucleophosmin/Nucleoplasmin-3(NPM3) and Hexokinase-1(HK1) confirmed c-Myc functional relevance and ChIP assays with HEK293T cells over-expressing ectopic c-Myc demonstrated enriched c-Myc occupancy at predicted TFBS for RCL1, NPM3, HK1 and RPSA. Note, c-Myc recruitment on chromatin was comparable to the positive controls CCND2 and CDK4. Computational analyses defined master regulators (MR), i.e. heterogeneous nuclear ribonucleoprotein A1, nucleolin, the apurinic/apyrimidinic endonuclease 1, triosephosphate-isomerase 1, folate transporter (SLC19A1) and nucleophosmin to influence activity of up to 90% of PLAC-regulated genes. Their expression was induced by 3-, 3-, 6-, 3-, 11- and 7-fold, respectively. STRING analysis confirmed protein-protein-interactions of regulated genes and Western immunoblotting of fatty acid synthase, serine hydroxyl-methyltransferase 1, arginine 1 and hexokinase 2 showed tumor specific induction. Published knock down studies confirmed these proteins to induce apoptosis by disrupting neoplastic lipogenesis, by endorsing uracil accumulation and by suppressing arginine metabolism and glucose-derived ribonucleotide biosynthesis. Finally, translational research demonstrated high expression of MR and of 47 PLAC up-regulated genes to be associated with poor survival in lung adenocarcinoma patients (HR 3.2 p < 0.001) thus, providing a rationale for molecular targeted therapies in PLACs.

Author Information

Yari Ciribilli

Prashant Singh

Alberto Inga

Jürgen Borlak
Primary Contact  _


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11804